Rajnish Wellness Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 541601 |
NSE Symbol : - |
P/E(TTM) : 169.00 |
ISIN Demat : INE685Z01033 |
Div & Yield% : - |
EPS(TTM) : 0.01 |
Book Value(₹) : 1.10 |
Market Cap(₹Cr) : 129.87 |
Face Value(₹) : 1.00 |
Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|---|---|
Gross Sales | 17.42 | 16.30 | 26.98 | 21.62 | 18.51 | 8.51 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 17.42 | 16.30 | 26.98 | 21.62 | 18.51 | 8.51 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 0.00 | 0.35 | 0.00 | 0.00 | 0.23 | 0.83 |
Total Income | 17.42 | 16.65 | 26.98 | 21.62 | 18.74 | 9.34 |
Total Expenditure | 16.94 | 16.29 | 26.44 | 21.32 | 18.46 | 8.48 |
PBIDT | 0.48 | 0.36 | 0.54 | 0.30 | 0.27 | 0.87 |
Interest | 0.10 | 0.13 | 0.11 | 0.12 | 0.14 | 0.13 |
PBDT | 0.38 | 0.23 | 0.43 | 0.17 | 0.13 | 0.73 |
Depreciation | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
Tax | 0.09 | 0.06 | 0.12 | 0.04 | 0.03 | 0.18 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.00 | 0.00 | 0.01 | 0.02 | 0.00 | 0.00 |
Reported Profit After Tax | 0.28 | 0.17 | 0.28 | 0.10 | 0.10 | 0.55 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 0.28 | 0.17 | 0.28 | 0.10 | 0.10 | 0.55 |
EPS (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
EPS (Adj) (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Calculated EPS (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Calculated EPS (Adj) (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Calculated EPS (Ann.) (Unit Curr.) | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 76.85 | 76.85 | 76.85 | 76.85 | 76.85 | 76.85 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 2.76 | 2.21 | 2.00 | 1.39 | 1.46 | 10.22 |
PBDTM(%) | 2.18 | 1.41 | 1.59 | 0.79 | 0.70 | 8.58 |
PATM(%) | 1.61 | 1.04 | 1.04 | 0.46 | 0.54 | 6.46 |